Kubota Ieko, Tsuboi Yoshiyuki, Shoda Emi, Kondo Masahiro, Masuda Yuji, Kitagawa Junichi, Oi Yoshiyuki, Iwata Koichi
Department of Anesthesiology, Nihon University School of Dentistry, 1-8-13 Kandasurugadai, Chiyoda-ku, Tokyo 101-8310, Japan.
Exp Brain Res. 2007 May;179(2):181-90. doi: 10.1007/s00221-006-0779-x. Epub 2006 Nov 30.
We studied Fos expression in the central nociceptive pathways at different sedative levels in order to clarify the central mechanism of propofol's nociceptive action. Sprague-Dawley rats received propofol (PRO) or pentobarbital (PEN) and were divided into two groups with different doses of drug administration (light and deep sedative levels) based on the electroencephalogram analysis. Rats at each sedative level received heat stimulation to their face and Fos immunohistochemistry was performed at various brain sites. We also infused lidocaine into the jugular vein to test whether PRO directly activated nociceptors distributed in the vein. Fos expression in two major ascending pain pathways (lateral and medial systems) and descending modulatory system were precisely analyzed following intravenous (i.v.) administration of PRO or PEN. Many Fos protein-like immunoreactive (Fos protein-LI) cells were expressed in the trigeminal spinal nucleus caudalis (Vc), parabrachial nucleus, parafascicular nucleus, a wide area of the primary somatosensory cortex, anterior cingulate cortex, amygdala, periaqueductal gray, solitary tract nucleus, and lateral hypothalamus following heating of the face during PRO or PEN infusion. The number of Fos protein-LI cells was significantly greater in many Central nervous system regions during PRO infusion compared with PEN. Fos expression was significantly greater in the Vc and Periaqueductal gray following greater amount of PRO infusions compared, whereas they were significantly smaller in the Vc in the rats with PEN infusion. The Fos expression was significantly depressed following i.v. infusion of lidocaine before PRO administration. The present findings suggest that PRO is involved in the enhancement of Vc activity through direct activation of the primary afferent fibers innervating veins, resulting in pain induction during infusion.
我们研究了不同镇静水平下中枢伤害性感受通路中的Fos表达,以阐明丙泊酚伤害性作用的中枢机制。将Sprague-Dawley大鼠给予丙泊酚(PRO)或戊巴比妥(PEN),并根据脑电图分析分为两组不同药物剂量给药组(轻度和深度镇静水平)。每个镇静水平的大鼠接受面部热刺激,并在不同脑区进行Fos免疫组织化学检测。我们还将利多卡因注入颈静脉,以测试PRO是否直接激活分布在静脉中的伤害感受器。在静脉注射PRO或PEN后,精确分析了两条主要的上行疼痛通路(外侧和内侧系统)和下行调节系统中的Fos表达。在PRO或PEN输注期间面部受热后,三叉神经尾侧脊核(Vc)、臂旁核、束旁核、初级体感皮层的广泛区域、前扣带回皮层、杏仁核、导水管周围灰质、孤束核和外侧下丘脑中有许多Fos蛋白样免疫反应性(Fos蛋白-LI)细胞表达。与PEN相比,在PRO输注期间,许多中枢神经系统区域中Fos蛋白-LI细胞的数量明显更多。与较少剂量的PRO输注相比,较多剂量的PRO输注后,Vc和导水管周围灰质中的Fos表达明显更高,而在PEN输注的大鼠中,Vc中的Fos表达明显更低。在PRO给药前静脉注射利多卡因后,Fos表达明显降低。目前的研究结果表明,PRO通过直接激活支配静脉的初级传入纤维参与Vc活性的增强,从而在输注期间诱导疼痛。